| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 07/12/1989 | EP0323805A2 Novel antibodies |
| 07/12/1989 | EP0323802A2 Monoclonal antibodies against, and cell surface antigen of, lung carcinoma |
| 07/12/1989 | EP0323769A1 Peptide structures, immunogens containing them, and their use in the control of fertility |
| 07/12/1989 | EP0323708A1 Rotavirus reassortant vaccine |
| 07/12/1989 | EP0323480A1 Genetically engineered vaccines for mycobacteria |
| 07/12/1989 | EP0191028B1 Molecule comprising at least one peptidic sequence carrying an epitope |
| 07/11/1989 | US4847363 Electrophoresis |
| 07/11/1989 | US4847240 Cationic polymers as transport carriers |
| 07/11/1989 | US4847081 Genetic engineering, cloning |
| 07/11/1989 | US4847080 Genetic engineering |
| 07/11/1989 | CA1257211A1 Process for obtaining a fviii/vwf complex having therapeutic effects and product thus prepared |
| 07/05/1989 | EP0323424A2 Peptide corresponding to HIV-env 583-599, and analogs thereof and applications of the peptides |
| 07/05/1989 | EP0323157A2 Antiviral compounds and methods |
| 07/05/1989 | EP0322990A1 Polypeptides and derivatives thereof as well as their use in pharmaceutical and diagnostic compositions |
| 07/05/1989 | EP0322712A2 DNA sequences specific for malaria, their expression products and applications thereof |
| 07/05/1989 | EP0322533A1 Bordetella pertussis toxin with altered toxicity |
| 07/05/1989 | EP0322417A1 Empty viral capsid vaccines |
| 07/05/1989 | CN1033569A Deactivated fat liquor vaccine of pork measles |
| 07/04/1989 | US4845200 Antitumor, drug delivery, side effect reduction |
| 07/04/1989 | US4845197 Monoclonal antibodies and methods for fungal pathogen detection |
| 07/04/1989 | US4845074 To kill viruses |
| 07/04/1989 | US4845036 Process for isolation of the B oligomer of pertussis toxin |
| 07/04/1989 | US4845026 Medical diagnosis and monitoring |
| 07/04/1989 | US4844895 Composition containing a peptide fragment of platelet factor four and method for restoring suppressed immune responses |
| 07/04/1989 | CA1256796A1 Cytotoxic conjugates which can be used in therapy and process for their preparation |
| 07/04/1989 | CA1256795A1 Anti-idiotype antibodies induced by synthetic polypeptides |
| 06/29/1989 | WO1989005856A1 Vaccines |
| 06/29/1989 | WO1989005855A1 Human cytomegalovirus protein |
| 06/29/1989 | WO1989005825A1 EXPRESSION OF RECOMBINANT 18/16.6 AND 15.2 kD PROTEIN ANTIGENS OF MYCOBACTERIUM LEPRAE |
| 06/29/1989 | WO1989005823A1 Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus |
| 06/29/1989 | WO1989005821A1 Hiv-related antigens and antibodies |
| 06/29/1989 | WO1989005820A1 Hiv-related antigens and antibodies |
| 06/29/1989 | WO1989005816A1 Cellular toxic conjugates |
| 06/29/1989 | WO1989005658A1 Proteins and process for preparing them, dna sequences, antibodies and their application, poxvirus, transformed or infected cells and pharmaceutical compositions useful for preventing toxoplasmosis |
| 06/29/1989 | WO1989005631A1 Compositions possessing immunostimulating properties and their applications in human and veterinary medecine |
| 06/28/1989 | EP0322402A2 Method and agents for measuring protein aging |
| 06/28/1989 | EP0322394A2 Expression of HIV proteins in E. coli and S. cerevisiae |
| 06/28/1989 | EP0322237A1 Vaccines |
| 06/28/1989 | EP0322146A2 Antibody and antigen |
| 06/28/1989 | EP0322115A2 Genetic detoxification of pertussis toxin |
| 06/28/1989 | EP0321606A1 Cellular amphipatic proteins in aggregated forms, and procedure for the production and purification of these proteins |
| 06/28/1989 | EP0321546A1 Immunoassay for aromatic ring containing compounds |
| 06/27/1989 | US4843146 Immunologically active polypeptides useful for the preparation of antimalarial vaccines and of diagnostic kits for the detection of antisporozoite antibodies |
| 06/27/1989 | US4843019 Monoclonal antibodies |
| 06/27/1989 | US4842999 Canine heartworm vaccine and diagnostic test |
| 06/27/1989 | CA1256370A1 Toxoids of elastase of pseudomonas aeruginosa origin |
| 06/27/1989 | CA1256368A1 Process for the preparation of an immune-reactive porous carrier material |
| 06/27/1989 | CA1256367A1 Fluorescence polarization immunoassay for heavy antigens |
| 06/21/1989 | EP0320942A2 Novel polysaccharides novel macromolecular conjugates of the polysaccharides |
| 06/21/1989 | EP0320866A2 A protective immunodominant epitope included in the S1 subunit of pertussis toxin |
| 06/21/1989 | EP0320840A2 Peptides, method for their preparation, antibodies to it, and their use in blocking the PAI-1 activity of human blood |
| 06/21/1989 | EP0320528A1 Use of hemocyanins and arylphorins for influencing the immune system and the treatment of tumors |
| 06/20/1989 | US4841025 Antibody preparations |
| 06/20/1989 | US4840895 Monoclonal antibodies reactive with immune complexes |
| 06/20/1989 | US4840894 Using protein antibody complex |
| 06/20/1989 | US4840794 Mastitis vaccine containing antigens from S. aureus |
| 06/20/1989 | CA1256250A1 Covalently-modified neutral bacterial poly- saccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins, and methods of preparing such polysaccharides and conjugates |
| 06/20/1989 | CA1256042A1 Process for the purification of hbsag |
| 06/20/1989 | CA1256024A1 Method of immunological dosage of monoamines |
| 06/15/1989 | WO1989005353A1 Common acute lymphoblastic leukemia antigen |
| 06/15/1989 | WO1989005348A1 Rhoptry antigen of plasmodium falciparum |
| 06/15/1989 | WO1989005307A1 Sf-25 colon adenocarcinoma antigen, and antibodies which recognize this antigen |
| 06/15/1989 | WO1989005306A1 Method and compositions relating to regression-associated antigens |
| 06/15/1989 | WO1989005305A1 Polymers and polymer-peptide conjugates |
| 06/15/1989 | WO1989005156A1 Carcinoma-associated antigens, and antibodies which recognize these antigens |
| 06/15/1989 | WO1989005155A1 Monoclonal antibody against the rgd-directed adhesion receptor of endothelial cells |
| 06/15/1989 | WO1989005154A1 Process for producing an avirulent cold blood virus |
| 06/15/1989 | WO1989005151A1 High integrity liposomes and method of preration and use |
| 06/15/1989 | WO1989004875A3 Characterization and detection of sequences associated with autoimmune diseases |
| 06/15/1989 | DE3733899A1 Products and methods for increasing growth rate and/or utilisation of food or nutrients and/or resistance in animals and humans |
| 06/14/1989 | EP0320495A1 Retrovirus of the type HIV-2 capable of inducing AIDS, and the antigenic and nucleic acid components thereof |
| 06/14/1989 | EP0320289A1 Methods and compositions for the production of haemophilus influenzae type B major outer membrane protein antigens |
| 06/14/1989 | EP0320152A2 Isolation of an immunoglobulin rich fraction from whey |
| 06/14/1989 | EP0320034A2 New immunologically active synthetic peptides useful for preparing an antimalarial vaccine |
| 06/14/1989 | EP0319815A2 Transfectant cell lines which express the major human rhinovirus receptor |
| 06/13/1989 | US4839288 Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes |
| 06/13/1989 | US4839275 Diagnosis of dog heartworms |
| 06/13/1989 | US4838852 Contacting with antigen, withdrawal blood, irradiating, returning to patient |
| 06/07/1989 | EP0319333A2 Method for the prevention of graft versus host disease |
| 06/07/1989 | EP0319253A2 Sialic acid glycosides, antigens, immunoadsorbents, and methods for their preparation |
| 06/07/1989 | EP0318948A2 Cleavable immunoconjugates for the delivery and release of agents in native form |
| 06/07/1989 | EP0318879A1 Vaccine against Schistosoma mansoni |
| 06/07/1989 | CN1033290A Production of chimeric antibodies by homologous recombination |
| 06/07/1989 | CN1033242A Method for decrease histic damage of imflammation region by monoclone antibody |
| 06/06/1989 | US4837306 Method for selecting hybridomas producing antibodies specific to the P-glycoprotein cell suface antigen and a cDNA clone encoding the C-terminal portion of the antigen |
| 06/06/1989 | US4837159 Method and apparatus for effecting immunological analysis |
| 06/06/1989 | US4837151 Live vaccines comprising two mutations and foreign antigen |
| 06/06/1989 | US4837018 Vaccines for fowl colibacillosis |
| 06/06/1989 | US4837016 Malaria vaccines |
| 06/06/1989 | US4837003 Radiolabeled antibody fragments |
| 06/06/1989 | CA1255216A1 Immunoassay for the detection of ligands |
| 06/01/1989 | WO1989004875A2 Characterization and detection of sequences associated with autoimmune diseases |
| 06/01/1989 | WO1989004873A1 Production of gonorrheal pi proteins and vaccines |
| 06/01/1989 | WO1989004872A1 Immunoreactive heterochain antibodies |
| 06/01/1989 | WO1989004869A1 Process for manufacturing antigens, vaccines and sera to combat bacterial or viral diseases and composition for implementing said process |
| 06/01/1989 | WO1989004841A1 Gastrointestinal tumor-associated glycoprotein expressing the ca 19-9 antigenic determinant |
| 06/01/1989 | WO1989004839A1 Improved ricin molecules and ricin toxin conjugates |
| 06/01/1989 | WO1989004835A1 HUMAN RESPIRATORY SYNCYTIALVIRUS VACCINE DERIVED FROM THE 1A (9.5 kD) PROTEIN |
| 06/01/1989 | WO1989004675A1 Selective removal of immune complexes |
| 06/01/1989 | WO1989004671A1 Differential delivery of therapeutic agents across the blood brain barrier |